A PET imaging scan of a human brain, with a multiple sclerosis lesion...
The image shows an MS lesion in the brain, marked in color. On the right is a close-up image of this broad-rim lesion.

Image source: University of Turku; adapted from: Klotz L, Smolders J, Lehto J et al., Nature Medicine 2025 (CC BY 4.0)

News • Promising biomarker found

Broad rim lesions predict multiple sclerosis progression

Researchers at the University of Turku have discovered a new biomarker that can predict the progression of multiple sclerosis (MS).

The thickness of the inflammatory cell rim surrounding brain lesions was found to directly correlate with the severity and speed of disease progression. The study, led at the University of Turku in Finland by Professor Laura Airas in collaboration with German and Dutch colleagues, has been published in the journal Nature Medicine.

Portrait photo of Prof. Laura Airas
Prof. Laura Airas

Image source: University of Turku

The research combined PET imaging data from 114 Finnish MS patients with post-mortem brain tissue analysis from Dutch MS patients. Results show that the wider the inflammatory rim around a brain lesion is, the more aggressively the disease advances. "When microglial cells form a thick rim around MS lesions, their harmful activity pushes deeper into healthy brain tissue, causing irreversible damage," says Professor Laura Airas. "This discovery allows us not only to identify patients who need more aggressive treatment earlier but also to evaluate the effectiveness of new drug candidates by observing changes in lesion rims." 

The findings are expected to improve the development of treatments particularly for progressive MS, the yet undertreated form of the disease. 

Professor Laura Airas is a research group leader at the InFLAMES Flagship, a joint initiative between the University of Turku and Åbo Akademi University, aiming to identify new drug targets and develop personalised therapies in collaboration with biotechnology and pharmaceutical companies. InFLAMES is part of the Flagship Programme of the Research Council of Finland. 


Source: University of Turku

05.05.2025

Related articles

Photo

News • Neurodegenerative diseases

Tauopathy or Alzheimer's? Biomarker and PET imaging for improved diagnosis

Researchers have identified biomarkers that, in conjunction with PET imaging, enable doctors to reliably distinguish between primary 4-repeat tauopathies and Alzheimer's disease.

Photo

News • Missed in MRI

Multiple sclerosis: PET scans reveal 'hidden' inflammation

In some patients with multiple sclerosis (MS), symptoms worsen during treatment, but MRI scans do not indicate any change. In such cases, positron emission tomography could help, a new study suggests.

Photo

News • Predictive psychiatry

Brain imaging finds biomarkers of mental illness

In a new study, researchers use a very large dataset to identify predictive brain imaging-based biomarkers of mental illness in adolescents.

Related products

Subscribe to Newsletter